Back

Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

28 August 2017 (14:18 - 14:28)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 3 Valvular heart disease, other ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Javier Bermejo Thomas

University Hospital Gregorio Maranon, Madrid (Spain)

14 More presentations in this session

Presentation thumbnail
Naturally randomized 'REVEAL' trial
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Discussant review: A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
Discussant review: Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.
Professor I. Lang (Vienna, AT)
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 3

The Event

Event poster

ESC Congress 2017

28 August 2017 14:18 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources